The global Blood Plasma Derivatives Market Growth Accelerated by Increasing Demand for Plasma Derived Medicines
Blood
plasma derivatives are derived from donated human blood plasma that are processed
and purified to manufacture therapeutics and medicines. Some key plasma
derivatives include immunoglobulins, albumin, coagulation factor concentrates,
protease inhibitors and other specialized medicines. These plasma derivatives
have wide application in treatment of immunodeficiency disorders, haemophilia,
hemorrhage and other chronic diseases. The growing prevalence of neurological,
immunological and bleeding disorders globally has substantially increased the
demand for plasma derived medicines in recent years.
The
global Blood Plasma Derivatives Market is estimated to be valued at US$ 44.33
Bn in 2023 and is expected to exhibit a CAGR
of 13% over the forecast period 2023 to 2030, as highlighted in a new
report published by Coherent Market Insights.
Market key trends:
The
growing demand for plasma derived medicines is a major driver of growth in the
blood plasma derivatives market. According to estimates, the global
immunoglobulin market size alone is projected to reach US$ 18 billion by 2025,
growing at a CAGR of 9% during the forecast period. The increasing adoption of
immunoglobulins in treatment of various autoimmune and inflammatory diseases is
expected to boost the growth of plasma derivatives market significantly over
the coming years. Furthermore, increasing investments by industry players for
expanding production facilities and growing access to plasma collection centers
especially in developing regions is also anticipated to cater to the
accelerating demand for cost-effective plasma medicines globally.
Segment Analysis
The Global
Blood Plasma Derivatives Market Size is dominated by the immunoglobulin
segment. Immunoglobulin has wide applications in treating various
immunodeficiency disorders such as Chronic Inflammatory Demyelinating Polyneuropathy
(CIDP) and others. The increasing prevalence of primary immunodeficiencies
worldwide is driving the demand for immunoglobulin in therapeutic applications.
Key Takeaways
The
global blood plasma derivatives market is expected to witness high growth during
the forecast period of 2023-2030. The market size is projected to reach US$
44.33 Bn by 2023, registering a CAGR of 13.%.
Regional analysis
North
America dominated the global market in 2022 and is expected to continue its
dominance during the forecast period. The rising cases of immune disorders and
trauma injuries in the region are driving the demand for blood plasma
derivatives. The presence of major players and increasing healthcare
expenditure also supports market growth in North America.
Key players
Key
players operating in the blood plasma derivatives market are Thermo Fisher
Scientific, Inc., Custom Biogenic Systems, Chart Biomedical Co. Ltd., Merck
KGaA, Barber-Nichols Inc., Praxair Technology, Inc., Linde LLC, Planer PLC,
Cryologic Pty. Ltd., Charter Medicals, Nikkiso Cryo Inc., Cryogenic Control,
and Haimen United Laboratory Equipment Development Co., Ltd.
Get More Insights On This Topic: https://www.newsstatix.com/blood-plasma-derivatives-market-size-share-analysis-2023-2030/
Comments
Post a Comment